0920-1317 COVID-19 Module Dialysis Outpatient Facility Form 27MAY2

National Healthcare Safety Network (NHSN) Coronavirus (COVID-19) Surveillance in Healthcare Facilities

Dialysis COVID 19 Reporting Form Final 9.5.4 Release

Dialysis Component

OMB: 0920-1317

Document [docx]
Download: docx | pdf


COVID19 Module

Dialysis Outpatient Facility


*required to save as complete

**conditionally required


Facility Operational Information

For the following questions, please collect data for the current reporting week. The reporting week is defined as Wednesday through Tuesday with reporting to occur on Wednesday by 3 PM ET. You should report on the same day each week, either close of business on Tuesday or Wednesday by the deadline. We advise you not to alternate reporting days.

_________

*Facility ID (OrgID)

_________

*CMS Certification Number (CCN)

_________

*Facility Name

_________

*Week of Data Collection

_________

*In-center Patient Census

_________

*Date last modified

_________

*Home Patient Census

_________

*Total Certified Stations

_________

*Isolation Stations Included in Total Certified Stations

 Yes

 No

*Is your facility a designated COVID unit?

 Yes

 No

*Does your facility have designated COVID shifts?


________

*Total number of staff (physician, nurses, techs, environmental services, biomed, etc.) who worked at least 1 day during the current reporting week


_________

How many patients on the current in-center census reside in nursing homes?


_________

How many patients on the current home census reside in nursing homes?


For the following questions, report data during the current reporting week which is Wednesday through Tuesday each week. For questions requiring counts, include only new data which has occurred during the current reporting week. Data should not be cumulative.


SARS-CoV-2 Positive (+) Patients and Staff


_________


*Number of newly confirmed in-center patients during the current reporting week


_________


*Number of newly confirmed in-center patients that reside in nursing homes during the current reporting week


_________


*Number of newly confirmed patients during the current reporting week that are home patients


_________


*Number of newly confirmed staff during the current reporting week


_________


*Number of SARS-CoV-2 patients who are currently admitted to the hospital during the current reporting week


_________


*Number of confirmed patients currently self-monitoring and continuing in-center therapy during the current reporting week


_________


*Number of confirmed patients currently self-monitoring and continuing home therapy during the current reporting week



Suspected SARS-CoV-2 Infection

_________


*Number of new suspect patient cases during the current reporting week

_________


*Number of new suspect staff cases during the current reporting week



Testing for SARS-CoV-2 Infection


_________


*Number of new patients who were recently tested for SARS-CoV-2 during the current reporting week


_________


*Of those new patients who were recently tested for SARS-CoV-2, how many had a negative SARS-CoV-2 test result during the current reporting week


_________


*Of those new patients who were recently tested for SARS-CoV-2, how many had a positive SARS-CoV-2 test result during the current reporting week


_________


*Of those new patients who were recently tested for SARS-CoV-2, how many had an unknown SARS-CoV-2 test result during the current reporting week



COVID-19 Vaccination Status:

____________

*Number of patients who have tested positive this current reporting week and have not received a COVID-19 vaccine or it has not been more than 14 days since the first dose of COVID-19 vaccine




_____________

*Number of patients who have been vaccinated with Pfizer-BioNTech COVID-19 vaccine and have tested positive for COVID-19 more than 14 days after:

*Dose 1_______

*Dose 2_______

____________

*Number of patients who have been vaccinated with Moderna COVID-19 vaccine and have tested positive for COVID-19 more than 14 days after:

*Dose 1 _______

*Dose 2 _______


____________

*Number of patients who have been vaccinated with Janssen COVID-19 vaccine and have tested positive more than 14 days after receiving the dose

____________

*Number of patients who have received a complete series of an Unspecified COVID-19 vaccine and have tested positive more than 14 days after receiving the dose



SARS-CoV-2 Positives (+) that have recovered

_________


*Number of patients recovered during the current reporting week

_________


*Number of staff recovered during the current reporting week


Suspected or Confirmed SARS-CoV-2 deaths


_________


*Number of patients with suspected or confirmed SARS-CoV-2 infection that have died during the current reporting week


_________


*Number of staff with suspected or confirmed SARS-CoV-2 infection that have died during the current reporting week


For the following questions, please collect data and report findings during the current reporting week


Staff and/or Personnel Impact

Will your facility have a critical shortage of staff and/or personnel within the next week?

Staffing Shortage?

Staff and Personnel Groups

 Yes

 No

Nursing Staff: registered nurse, licensed practical nurse, vocational nurse

 Yes

 No

Clinical Staff: physician, physician assistant, advanced practice nurse

 Yes

 No

Tech: dialysis technician


 Yes

 No

Other staff or facility personnel, regardless of clinical responsibility or patient contact not included in the categories above (for example, environmental services, biomed)


Supplies & Personal Protective Equipment (PPE)

Supply Item

Do you currently have any supply?

Do you have enough for one week if using conventional strategies?

N95 masks

 Yes

 No

 Yes

 No

Surgical masks or medical facemasks

 Yes

 No

 Yes

 No

Eye protection, including face shields or goggles

 Yes

 No

 Yes

 No

Single-use Isolation Gowns

 Yes

 No

 Yes

 No

Gloves

 Yes

 No

 Yes

 No

Alcohol-based hand sanitizer

 Yes

 No

 Yes

 No



Laboratory Testing

 Yes

 No

Does your facility have the ability to collect specimens onsite for SARS-CoV-2 testing?

 Viral (PCR)

 Antigen

 Antibody

**If yes, what types of specimens are being collected?

 NP swab

 Anterior Nares swab

 Mid Turbinate swab

 OP swab

 Saliva

**If yes to viral (PCR) tests, what types of specimens are being collected?

Lack of recommended personal protective equipment (PPE) for personnel to wear during specimen collection

Lack of supplies for specimen collection

Lack of access to a laboratory for submitting specimens

Lack of access to trained personnel to perform testing

Uncertainty about testing reimbursement

Other: Specify__________________________


**If no, indicate reasons why specimens are not being collected onsite for SARS-CoV-2 testing?

 Yes

 No

If yes, does your facility have an in-house point-of-care test machine (capability to perform SARS-CoV-2 testing within your facility)?



File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorNovosad, Shannon A. (CDC/DDID/NCEZID/DHQP)
File Modified0000-00-00
File Created2021-05-31

© 2024 OMB.report | Privacy Policy